June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Refractive Outcomes of Toric Intraocular Lens Implantation for Correction of Astigmatism During Cataract Surgery
Author Affiliations & Notes
  • Naveen Rao
    Ophthalmology, Lahey Clinic, Burlington, MA
    Ophthalmology, Tufts Medical Center, Boston, MA
  • Amal Althawabi
    Ophthalmology, Lahey Clinic, Burlington, MA
  • Kirstin Tawse
    Ophthalmology, Tufts Medical Center, Boston, MA
  • Sarkis Soukiasian
    Ophthalmology, Lahey Clinic, Burlington, MA
    Ophthalmology, Tufts Medical Center, Boston, MA
  • Footnotes
    Commercial Relationships Naveen Rao, Alcon (R); Amal Althawabi, None; Kirstin Tawse, None; Sarkis Soukiasian, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1848. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Naveen Rao, Amal Althawabi, Kirstin Tawse, Sarkis Soukiasian; Refractive Outcomes of Toric Intraocular Lens Implantation for Correction of Astigmatism During Cataract Surgery. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1848.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To establish criteria for determining quality of refractive outcomes after toric intraocular lens (IOL) implantation. To assess whether implantation of toric IOLs with higher cylindrical power is associated with inferior refractive outcomes.

Methods: Charts were reviewed for patients who underwent cataract surgery and toric IOL implantation with the Alcon AcrySof Toric IQ lens at Lahey Clinic from July 2009 - June 2012. Data collected included: cylindrical power of toric IOL used; postoperative uncorrected distance visual acuity (UDVA); postoperative corrected distance visual acuity (CDVA); postoperative residual astigmatism by manifest refraction; and presence of ocular co-morbidities. Eyes were assigned to groups based on outcomes defined as good (UDVA 20/25 or better with ≤ 0.50 D residual astigmatism), fair (either UDVA 20/30 with ≤ 0.50 D residual astigmatism, or UDVA 20/25 or better with 0.75 D residual astigmatism), and poor (UDVA 20/30 or worse with ≥ 0.75 D residual astigmatism).

Results: 133 eyes of 96 patients were included. 56.4% (n=75), 16.5% (n=22), and 27.1% (n=36) of eyes met criteria for the good, fair, and poor outcome groups, respectively. In the good outcome group, mean postoperative UDVA was 20/22 and mean residual astigmatism was 0.14±0.22 D. In the fair outcome group, mean postoperative UDVA was 20/28 and mean residual astigmatism was 0.38±0.33 D. In the poor outcome group, mean postoperative UDVA was 20/44 and mean residual astigmatism was 0.79±0.31 D. 13.5% of eyes (n=18) had ocular co-morbidities (corneal or retinal pathology) that limited postoperative CDVA; all met criteria for the poor outcome group. 38.4% (n=51) of eyes received implantation of the lowest cylindrical power toric IOL (T3), and 61.6% (n=82) of eyes received implantation of higher cylindrical power toric IOLs (T4-T9). There was no significant difference in postoperative UDVA between the T3 and T4-T9 groups (20/26 versus 20/28, p=0.3537). Residual astigmatism was lower in the T3 group than in the T4-T9 group (0.24±0.33 D versus 0.43±0.46 D, p=0.0115).

Conclusions: Establishing criteria for determining quality of refractive outcomes after toric IOL implantation can be helpful in counseling patients before cataract surgery. Implantation of higher cylindrical power toric IOLs is associated with slightly more residual astigmatism, but there is no association with inferior postoperative UDVA.

Keywords: 428 astigmatism • 445 cataract • 733 topography  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×